Oxycodone/Naloxone controlled-release

DRUG3 trials

Sponsors

Purdue Pharma LP

Conditions

Low Back Pain

Phase 3

Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

CompletedNCT01358526

Purdue Pharma LPLow Back Pain

Start: 2011-05-31End: 2012-11-30Updated: 2015-11-11

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

CompletedNCT01427283

Purdue Pharma LPLow Back Pain

Start: 2011-08-31End: 2014-10-31Updated: 2015-02-12

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

CompletedNCT01427270

Purdue Pharma LPLow Back Pain

Start: 2011-08-31End: 2014-10-31Updated: 2014-11-07